These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 192128)

  • 1. [Pathogenesis and treatment of congenital nephrogenic diabetes insipidus (author's transl)(proceedings)].
    Dubost M; Berthezène F; Pousset G; Orgiazzi J; Accominotti JC
    Ann Endocrinol (Paris); 1976; 37(4):313-4. PubMed ID: 192128
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital nephrogenic diabetes insipidus with bilateral hydronephrosis: indomethacin in treatment of nephrogenic diabetes insipidus.
    Sohn YM; Lee C; Kim PK; Yun DJ
    Yonsei Med J; 1980; 21(2):116-22. PubMed ID: 7314648
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of nephrogenic diabetes insipidus].
    Cavallini L; Botto JA
    Rev Sanid Milit Argent; 1966; 65(1):54-6. PubMed ID: 5986733
    [No Abstract]   [Full Text] [Related]  

  • 4. The combined effect of chlorpropamide and chlorothiazide upon the response to vasopressin (Pitressin) in rats with hereditary diabetes insipidus.
    Laycock JF; Lee J; Lewis AF
    J Anat; 1972 Feb; 111(Pt 2):329. PubMed ID: 5039189
    [No Abstract]   [Full Text] [Related]  

  • 5. Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Ruel N; Arthus MF; Lonergan M
    Nephron; 1990; 56(4):449-50. PubMed ID: 1964202
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital nephrogenic diabetes insipidus in a baby girl.
    Schreiner RL; Skafish PR; Anand SK; Northway JD
    Arch Dis Child; 1978 Nov; 53(11):906-8. PubMed ID: 215090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Kuzemko JA; Robson JE
    Br J Clin Pract; 1966 Oct; 20(10):521-4. PubMed ID: 5950653
    [No Abstract]   [Full Text] [Related]  

  • 8. Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.
    Valtin H; Coffey AK; O'Sullivan DJ; Homma S; Dousa TP
    Physiol Bohemoslov; 1990; 39(1):103-11. PubMed ID: 2165265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of congenital diabetes insipidus--study on its therapy and physiopathology].
    Tsuchiya Y; Kumagai M; Matsuo S
    Horumon To Rinsho; 1975 Jun; 23(6):621-5. PubMed ID: 1170982
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperuricemia, a concomitant of congenital vasopressin-resistant diabetes insipidus in the adult.
    Gorden P; Robertson GL; Seegmiller JE
    N Engl J Med; 1971 May; 284(19):1057-60. PubMed ID: 5553195
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of exogenous 3':5'-adenosine monophosphate on urinary output in children with vasopressin-resistant diabetes insipidus.
    Proesmans W; Eggermont E; Vanderschueren-Lodeweyckx M; Tiddens H; Eeckels R
    Pediatr Res; 1975 May; 9(5):509-12. PubMed ID: 166349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetes insipidus of traumatic origin. Problems of diagnosis and treatment].
    Giménez Méndez JP; Ramón Soler R; Vences Quintela A; Bellorbi I; Cuatrecasas G; Mas Marfany J
    Rev Esp Anestesiol Reanim; 1980 Jul; 27(4):351-6. PubMed ID: 7209072
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of diabetes insipidus.
    Randall RV
    Mod Treat; 1966 Jan; 3(1):181-8. PubMed ID: 5904577
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal effects of cyclic AMP in normal and congenital diabetes insipidus rats.
    Martinez-Maldonado M; Stavroulaki-Tsapara A; Eknoyan G
    Life Sci; 1974 May; 14(10):2025-30. PubMed ID: 4368011
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (author's transl)].
    Irmscher K; Sennejunker K; Wiegelmann W; Solbach HG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2431-7. PubMed ID: 4614967
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.
    Uttley WS; Atkinson B; Adams A; Shirling D
    J Inherit Metab Dis; 1978; 1(2):75-7. PubMed ID: 229343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Congenital nephrogenic diabetes insipidus].
    Thibonnier M
    Rev Prat; 1994 May; 44(9):1169-72. PubMed ID: 7939338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic diabetes insipidus. Effects of 3,5, cyclic-adenosine monophosphate.
    Jones NF; Barraclough MA; Barnes N; Cottom DG
    Arch Dis Child; 1972 Oct; 47(255):794-7. PubMed ID: 4343784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes insipidus and pregnancy (author's transl)].
    Barchatowa TP; Ljaschko ES
    Zentralbl Gynakol; 1980; 102(20):1148-50. PubMed ID: 7211014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.